soul trial oral semaglutide cardiovascular outcomes 2024 nejm and in Type 2 Diabetes soul trial oral semaglutide cardiovascular

Pretoria: South African health regulators have ordered the urgent recall of compounded weight-loss and diabetes medicines containing semaglutide, tirzepatide

In this episode, we explore the use of GLP-1 therapy for weight management beyond diabetes, including who may benefit and who should avoid it.

The global semaglutide market is entering a new phase, following the first wave of generic launches in India and expanding soon into markets such as Brazil.

he had acute and progressive renal failure

For patients pursuing serious, sustained weight management who meet clinical criteria

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results presented at ASCO Gastrointestinal Cancers Symposium.A retrospective analysis of more than 281,000 people showed those who used GLP-1s exhibited a 36% reduced risk for colorectal cancer compared with those who used aspirin